SOPHiA GENETICS SA (SOPH)
2.90
0.01 (0.35%)
At close: Apr 15, 2025, 3:59 PM
2.91
0.50%
After-hours: Apr 15, 2025, 06:00 PM EDT
0.35% (1D)
| Bid | 2.7 |
| Market Cap | 193.81M |
| Revenue (ttm) | 65.17M |
| Net Income (ttm) | -62.49M |
| EPS (ttm) | -0.95 |
| PE Ratio (ttm) | -3.05 |
| Forward PE | -6.17 |
| Analyst | Buy |
| Ask | 3.13 |
| Volume | 14,670 |
| Avg. Volume (20D) | 78,955 |
| Open | 2.94 |
| Previous Close | 2.89 |
| Day's Range | 2.81 - 2.94 |
| 52-Week Range | 2.60 - 6.28 |
| Beta | 1.02 |
About SOPH
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Su...
Sector Healthcare
IPO Date Jul 23, 2021
Employees 423
Stock Exchange NASDAQ
Ticker Symbol SOPH
Website https://www.sophiagenetics.com
Analyst Forecast
According to 2 analyst ratings, the average rating for SOPH stock is "Buy." The 12-month stock price forecast is $6.5, which is an increase of 124.14% from the latest price.
Stock ForecastsNext Earnings Release
SOPHiA GENETICS SA is scheduled to release its earnings on May 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-1.12%
SOPHiA GENETICS shares are trading higher after th...
Unlock content with
Pro Subscription
5 months ago
-9.33%
Sophia Genetics shares are trading lower. The stock may be moving on continued weakness following a Q3 earnings miss on Tuesday.
